药品注册-话题@MedSci

#药品注册#

26篇内容 | 975人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1440622, encodeId=bd7f14406228a, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=中外制药的骨质疏松症治疗药“艾地罗”在中国取得药品注册证书, objectType=article, longId=204658, objectId=cc8b204658b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc8b204658b3, replyNumber=0, likeNumber=34, createdTime=2020-12-20, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc8b204658b3, moduleTitle=中外制药的骨质疏松症治疗药“艾地罗”在中国取得药品注册证书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc8b204658b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440621, encodeId=ae7f144062135, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=31条修改，《药品注册管理办法》再次发布征求意见稿, objectType=article, longId=181537, objectId=90e518153e5e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e518153e5e, replyNumber=0, likeNumber=37, createdTime=2019-10-20, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e518153e5e, moduleTitle=31条修改，《药品注册管理办法》再次发布征求意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90e518153e5e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440620, encodeId=e20c1440620eb, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=8款药品注册申请拟纳入优先审评, objectType=article, longId=163416, objectId=267c163416c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=267c163416c6, replyNumber=0, likeNumber=28, createdTime=2019-04-03, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=267c163416c6, moduleTitle=8款药品注册申请拟纳入优先审评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=267c163416c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440619, encodeId=dbf614406199e, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=国家药管局药品注册管理司司长王平：罕见病治疗药品3个月内完成审结, objectType=article, longId=162864, objectId=abe816286406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abe816286406, replyNumber=0, likeNumber=40, createdTime=2019-03-26, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abe816286406, moduleTitle=国家药管局药品注册管理司司长王平：罕见病治疗药品3个月内完成审结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abe816286406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440618, encodeId=36081440618a7, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=2019两会｜药品注册慢、评审水平差怎么办？听代表委员这么说, objectType=article, longId=162249, objectId=b20f1622496f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b20f1622496f, replyNumber=0, likeNumber=41, createdTime=2019-03-14, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b20f1622496f, moduleTitle=2019两会｜药品注册慢、评审水平差怎么办？听代表委员这么说, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b20f1622496f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440617, encodeId=8ffd144061e87, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=国务院：取消国产药品注册初审等25项行政许可事项, objectType=article, longId=161928, objectId=55f516192877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55f516192877, replyNumber=0, likeNumber=44, createdTime=2019-03-10, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55f516192877, moduleTitle=国务院：取消国产药品注册初审等25项行政许可事项, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55f516192877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440616, encodeId=e664144061666, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=开创新时代药品监管新格局全国药品注册管理和上市后监管工作会议在京召开, objectType=article, longId=158644, objectId=7084158644c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7084158644c4, replyNumber=0, likeNumber=30, createdTime=2019-01-24, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7084158644c4, moduleTitle=开创新时代药品监管新格局全国药品注册管理和上市后监管工作会议在京召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7084158644c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440615, encodeId=3f0b144061529, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=药品注册审评审批效率进一步提升, objectType=article, longId=139021, objectId=d471139021e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d471139021e8, replyNumber=0, likeNumber=31, createdTime=2018-05-26, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d471139021e8, moduleTitle=药品注册审评审批效率进一步提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d471139021e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440614, encodeId=f015144061498, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=药品注册审评专家咨询委员会初选名单出炉, objectType=article, longId=126576, objectId=896b1265e687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896b1265e687, replyNumber=0, likeNumber=39, createdTime=2018-01-17, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896b1265e687, moduleTitle=药品注册审评专家咨询委员会初选名单出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896b1265e687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440613, encodeId=84aa1440613dc, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=食药监总局：药品注册申请将调整为总局集中受理, objectType=article, longId=119961, objectId=a8c911996137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c911996137, replyNumber=0, likeNumber=29, createdTime=2017-11-15, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c911996137, moduleTitle=食药监总局：药品注册申请将调整为总局集中受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8c911996137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440612, encodeId=1d0614406123d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=生物制品新分类细胞治疗按药品注册上市, objectType=article, longId=117683, objectId=a21311e68364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a21311e68364, replyNumber=0, likeNumber=44, createdTime=2017-10-28, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a21311e68364, moduleTitle=生物制品新分类细胞治疗按药品注册上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a21311e68364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440611, encodeId=226114406118d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=药品注册管理办法修订稿征求意见：设立优先审评审批制度, objectType=article, longId=117491, objectId=de2011e491ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de2011e491ae, replyNumber=0, likeNumber=26, createdTime=2017-10-26, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de2011e491ae, moduleTitle=药品注册管理办法修订稿征求意见：设立优先审评审批制度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de2011e491ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440610, encodeId=0b0b144061004, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=《关于调整进口药品注册管理有关事项的决定》政策解读, objectType=article, longId=115803, objectId=1e95115803e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e95115803e7, replyNumber=0, likeNumber=36, createdTime=2017-10-13, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e95115803e7, moduleTitle=《关于调整进口药品注册管理有关事项的决定》政策解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e95115803e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440609, encodeId=e06f144060927, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=进口药品注册管理施行新规，官方解答六疑问, objectType=article, longId=115792, objectId=9d54115e92fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d54115e92fa, replyNumber=0, likeNumber=28, createdTime=2017-10-12, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d54115e92fa, moduleTitle=进口药品注册管理施行新规，官方解答六疑问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d54115e92fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440608, encodeId=9b64144060850, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=勃林格殷格, 抗肺纤维化, 维加特, 尼达尼布, 药品注册证, objectType=article, longId=115677, objectId=58b71156e766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58b71156e766, replyNumber=0, likeNumber=22, createdTime=2017-10-12, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58b71156e766, moduleTitle=勃林格殷格, 抗肺纤维化, 维加特, 尼达尼布, 药品注册证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58b71156e766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440607, encodeId=15ee144060e0d, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=CFDA征求意见：计划收回省局大部分药品注册受理权, objectType=article, longId=113019, objectId=1bc6113019fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc6113019fe, replyNumber=0, likeNumber=26, createdTime=2017-09-18, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc6113019fe, moduleTitle=CFDA征求意见：计划收回省局大部分药品注册受理权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc6113019fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440606, encodeId=aad3144060665, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=2017H1国内药品注册申报态势：1类新药井喷东阳光大爆发, objectType=article, longId=104411, objectId=af29104411ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af29104411ae, replyNumber=0, likeNumber=30, createdTime=2017-07-05, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af29104411ae, moduleTitle=2017H1国内药品注册申报态势：1类新药井喷东阳光大爆发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af29104411ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440605, encodeId=2c88144060544, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=我国药品审评审批制度改革显成效，基本消除药品注册申请积压, objectType=article, longId=103084, objectId=472f1030845b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=472f1030845b, replyNumber=0, likeNumber=27, createdTime=2017-06-24, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472f1030845b, moduleTitle=我国药品审评审批制度改革显成效，基本消除药品注册申请积压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=472f1030845b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440604, encodeId=c6c214406044b, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=华杰鸿：CFDA成为国际药品注册标准制订者之一, objectType=article, longId=102785, objectId=098b102e854e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098b102e854e, replyNumber=0, likeNumber=37, createdTime=2017-06-23, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098b102e854e, moduleTitle=华杰鸿：CFDA成为国际药品注册标准制订者之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098b102e854e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1440603, encodeId=d40c1440603bc, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, objectTitle=《药品注册管理办法》9年后最重大修改（附修订稿 VS 2007版）, objectType=article, longId=73838, objectId=f54ce383840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f54ce383840, replyNumber=0, likeNumber=29, createdTime=2016-07-28, rootId=0, userName=1508842480_96220438, userId=e3f64741524, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f54ce383840, moduleTitle=《药品注册管理办法》9年后最重大修改（附修订稿 VS 2007版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f54ce383840)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药品注册

2020-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#药品注册#

中外制药的骨质疏松症治疗药“艾地罗”在中国取得药品注册证书

2020-12-20

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

31条修改，《药品注册管理办法》再次发布征求意见稿

2019-10-20

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

8款药品注册申请拟纳入优先审评

2019-04-03

docwu2019 (审核中...)

前往app查看评论内容

#药品注册#

国家药管局药品注册管理司司长王平：罕见病治疗药品3个月内完成审结

2019-03-26

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

2019两会｜药品注册慢、评审水平差怎么办？听代表委员这么说

2019-03-14

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

国务院：取消国产药品注册初审等25项行政许可事项

2019-03-10

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

开创新时代药品监管新格局全国药品注册管理和上市后监管工作会议在京召开

2019-01-24

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

药品注册审评审批效率进一步提升

2018-05-26

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

药品注册审评专家咨询委员会初选名单出炉

2018-01-17

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

食药监总局：药品注册申请将调整为总局集中受理

2017-11-15

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

生物制品新分类细胞治疗按药品注册上市

2017-10-28

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

药品注册管理办法修订稿征求意见：设立优先审评审批制度

2017-10-26

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

《关于调整进口药品注册管理有关事项的决定》政策解读

2017-10-13

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

进口药品注册管理施行新规，官方解答六疑问

2017-10-12

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

勃林格殷格, 抗肺纤维化, 维加特, 尼达尼布, 药品注册证

2017-10-12

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

CFDA征求意见：计划收回省局大部分药品注册受理权

2017-09-18

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

2017H1国内药品注册申报态势：1类新药井喷东阳光大爆发

2017-07-05

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

我国药品审评审批制度改革显成效，基本消除药品注册申请积压

2017-06-24

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

华杰鸿：CFDA成为国际药品注册标准制订者之一

2017-06-23

1508842480_96220438 (审核中...)

前往app查看评论内容

#药品注册#

《药品注册管理办法》9年后最重大修改（附修订稿 VS 2007版）

2016-07-28

科室
- - 订阅+
  - 更多科室
工具
服务